Back to Authors

Kaufmann, Scott H.

https://orcid.org/0000-0002-4900-7145

A5054370710 | I1330342723

Mayo Clinic

Mayo Clinic

Citations 321

Faculty Opinions recommendation of Topoisomerase inhibitors and targeted delivery in cancer therapy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | September 18, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.736613832.793565211

Faculty Opinions recommendation of Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | September 18, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.735680777.793565214

Faculty Opinions recommendation of Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive gastric cancer: a dose-expansion, phase 1 study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | September 18, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.735680776.793565215

Faculty Opinions recommendation of NCI Comparative Oncology Program Testing of Non-Camptothecin Indenoisoquinoline Topoisomerase I Inhibitors in Naturally Occurring Canine Lymphoma.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | September 18, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.733721497.793565212

Faculty Opinions recommendation of Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | September 18, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.735124171.793565217

Faculty Opinions recommendation of The essential kinase ATR: ensuring faithful duplication of a challenging genome.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | September 18, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.728649753.793565220

Faculty Opinions recommendation of Therapy of Small Cell Lung Cancer (SCLC) with a Topoisomerase-I-inhibiting Antibody-Drug Conjugate (ADC) Targeting Trop-2, Sacituzumab Govitecan.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | September 18, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.727782010.793565218

Faculty Opinions recommendation of Therapy of Advanced Non-Small-Cell Lung Cancer With an SN-38-Anti-Trop-2 Drug Conjugate, Sacituzumab Govitecan.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | September 18, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.727655431.793565216

Faculty Opinions recommendation of AZD6738, A Novel Oral Inhibitor of ATR, Induces Synthetic Lethality with ATM Deficiency in Gastric Cancer Cells.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | September 18, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.727254915.793565221

Faculty Opinions recommendation of Rational Design of 5-(4-(Isopropylsulfonyl)phenyl)-3-(3-(4-((methylamino)methyl)phenyl)isoxazol-5-yl)pyrazin-2-amine (VX-970, M6620): Optimization of Intra- and Intermolecular Polar Interactions of a New Ataxia Telangiect

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | September 17, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.735738721.793565222